Genetic studies of depleting either m6A methyltransferases, such as METTL3 and METTL14 or demethylase FTO (fat mass and obesity associated protein), have demonstrated their important roles in controlling cortical development and regulating brain cognitive functions [16,43,44]. The gene discussed is MBD2; the disease is obesity due to melanocortin 4 receptor deficiency.